Nutriband Inc.

NTRB | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.05

-$0.72 (-9.27%)

Sep 22, 2026, 1:21 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-9.27%

(1D)

Rating

Updated: Aug 10, 2026

23.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $85.76M

1D Range

6.80 7.88

52W Range

2.80 8.63

Valuation (TTM)

PE -13.63

PB 17.73

EV/EBITDA -13.33

Valuation (NTM)

Forward PE 5.17

Forward PEG -0.10

Price Target N/A

Cash Flow

FCF Yield -3.9%

SBC Adj. FCF Yield -7.5%

SBC Impact -93.8%

Margins

Gross Margin 33.1%

Operating Margin -435.6%

FCF Margin -224.6%

Growth (CAGR)

Revenue 3Y | 5Y -10.8% | 3.1%

Dil EPS 3Y | 5Y 8.5% | -14.1%

FCF 3Y | 5Y 7.3% | -1.8%

Returns

ROA -110.6%

ROE -109.0%

ROIC -127.0%

Financial Health

Net Cash

$3.23M

Current Ratio 4.21

Interest Coverage -339.35

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fen...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Sep 30, 2021

Website nutriband.com

Fiscal Year February - January

Full Company Profile

Latest News

No news articles available yet.